Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-11-27
1992-09-08
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514249, 514260, 514258, 544258, 544279, 544287, C07D40102, A61K 31505
Patent
active
051458543
ABSTRACT:
A 10-deaza-10-formyl folate analogue is a potent inhibitor of the enzyme glycinamide ribonucleotide formyltransferase and an antitumor agent. A typical embodiment is 10-formyl-5,8,10-trideazafolic acid (FTDF).
REFERENCES:
patent: 3472851 (1984-10-01), Davoll
patent: 4447608 (1984-05-01), Jones et al.
patent: 4857530 (1989-08-01), Berman et al.
patent: 4889859 (1989-12-01), Taylor et al.
patent: 4981856 (1991-01-01), Hughes et al.
patent: 4992550 (1991-02-01), Hughes
Nair, Nanavati et al. J. Med. Chem 29, 1754, 1986.
Nair et al. J. Med. Chem 30, 1256, 1987.
Li Shu W.
Nair Madhavan G.
LandOfFree
1-formyl-5,8,10-trideazafolates does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1-formyl-5,8,10-trideazafolates, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-formyl-5,8,10-trideazafolates will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-134481